Proteomics: Professor John Yates of the Scripps Research Institute Shares His Latest Insights
Discover how stable isotopes are being used in world-leading quantitative proteomics research at the Yates Laboratory
Discover how stable isotopes are being used in world-leading quantitative proteomics research at the Yates Laboratory
Findings indicate increased specificity in low-risk populations and potential for monitoring tuberculosis treatment
Automated repeat and confirmatory testing of reactive samples through SMART algorithm software and Hot Zone capabilities reduce the need for additional testing
Dr. Del Trezise answers your questions about using real-time cell imaging to gain deeper insights into immune cells
Discover why recombinantly engineered REAfinity Antibodies offer improved consistency, reproducibility and purity over traditionally produced monoclonal antibodies
Meet the couple combining stroke research & Alzheimer’s expertise in the hope of understanding mixed dementia
Public-private partnership aims to standardize and clinically validate blood-based biomarkers
Booth #2607
New test provides improved accuracy in identification of HCV genotype and subtype for guiding selection of optimal therapeutic treatment for individuals with Hepatitis C
Deriving deeper biological insight and improving productivity in immune cell biology
Professor David R. Greaves, University of Oxford, UK, discusses the technology that is enabling him to research tissue repair and chronic inflammation in real time
B Medical Systems donates lifesaving cold chain equipment to Myanmar, as part of its social responsibility program
Selected for screening of 340,000 recruits in 2017 as part of national TB control strategy
The first chemically-defined, animal component-free, cell culture medium for T cells
How Biotix is changing what researchers expect from a tip
Learn how the maternal immune profile of mothers can predict neurodevelopmental abnormalities
New service gives all researchers exclusive access to liquid biopsy-based tools
Circulogene’s core technology enables cell-free DNA monitoring in oncology